Webinar: Buy and Bill Reimbursement. Use of “Buy and Bill” as we have known it for years in the traditional commercial market continues to change and changes will not abate in 2017. The question to be answered is this method of drug use reimbursement just changing, dying or dead?
Traditional Buy & Bill refers to the process of physician management through buying and billing on certain medicines, primarily specialty medicines that require injection or infusion.
Webinar: Buy and Bill Reimbursement presented by Access Market Intelligence identifies and reviews the key trends identified in our research reports that will impact primarily impact Buy & Bill strategies for 2017 and beyond. This webinar will benefit:
- Professionals with Pharmaceutical, Medical Device, and Diagnostic companies who sell and contract with third party Payors, health insurers, and others.
- Professionals engaged with Field Sales, Marketing, Account Management and Contracting for access will especially find this Webinar useful in crafting their 2017 plans.
In this webinar you will learn more about the drivers behind the significant changes underway in the marketplace around Buy and Bill, including:
- The impact of the ACA and the move away from fee-for-service to risk-based contracting.
- The influence of self-insured plans on health plans spending the current market shift away from Buy & Bill.
PURCHASE for $99: this 60-minute webinar recording which includes a 15-minute Q&A and the slides used in the presentation.
Marc Fluitt is Vice President of National Institute of Collaborative Healthcare (NICH), a pharmacist and former marketing and sales executive with 24 years of pharmaceutical industry experience, including large account management accomplishments. Spearheading innovative initiatives with a specialty pharmacy, copay assistance programs, electronic prescribing, Health Economic & Outcomes Trials, and customized clinical literature he has improved and maintained access for products. He has also designed and implemented many successful pull-through campaigns for sales forces that maximize profitability.
Dr. F. Randy Vogenberg is a Partner at Access Market Intelligence (AMI) and NICH. He has over 40 years of practical work experience in the healthcare industry. Randy holds a Bachelor of Science degree in Pharmacy, and a Doctorate in Health Care Management. As the Strategic Pharmacy Advisor and Co-Project Leader with the Midwest Business Group on Health National Employer Initiative on Biologics & Specialty Drugs, Randy identifies best and worst cases in health coverage to determine potential solutions that employers can implement or manufacturers could incorporate into their U.S. marketing or sales strategies.